|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2001-10-15
|
|
pubmed:abstractText |
To define the activity and feasibility of brief-duration high-intensity chemotherapy for adults with small noncleaved, non-Hodgkin's lymphoma (SNC) and the L3 variant of acute lymphocytic leukemia (L3 ALL).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4014-22
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11600602-Adult,
pubmed-meshheading:11600602-Aged,
pubmed-meshheading:11600602-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11600602-Central Nervous System,
pubmed-meshheading:11600602-Cyclophosphamide,
pubmed-meshheading:11600602-Cytarabine,
pubmed-meshheading:11600602-Drug Administration Schedule,
pubmed-meshheading:11600602-Etoposide,
pubmed-meshheading:11600602-Female,
pubmed-meshheading:11600602-Humans,
pubmed-meshheading:11600602-Ifosfamide,
pubmed-meshheading:11600602-Infection,
pubmed-meshheading:11600602-Injections, Spinal,
pubmed-meshheading:11600602-Lymphoma, Non-Hodgkin,
pubmed-meshheading:11600602-Male,
pubmed-meshheading:11600602-Methotrexate,
pubmed-meshheading:11600602-Neutropenia,
pubmed-meshheading:11600602-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:11600602-Prednisone,
pubmed-meshheading:11600602-Survival Analysis,
pubmed-meshheading:11600602-Thrombocytopenia,
pubmed-meshheading:11600602-Vincristine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.
|
|
pubmed:affiliation |
Department of Medicine, the Alvin and Lois Lapidus Cancer Institute, Sinai Hospital, Baltimore, MD, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Review
|
